Business Wire

TATA-MOTORS

Share
New Paradigm of Innovation: Tata Passenger Electric Mobility Proudly Showcases Its New Vision, a Concept Built on Its Pure EV Architecture

Taking a giant stride towards the next generation of electric vehicles, Tata Passenger Electric Mobility (TPEM) today made a smashing debut with the global unveil of the AVINYA Concept – an expression of the Company’s vision of a pure electric vehicle, based on its GEN 3 architecture. Derived from the Sanskrit language, the name AVINYA stands for ‘Innovation’. The AVINYA Concept introduces a new typology of mobility that liberates enormous roominess and comfort, not restricted by traditional segmentation. It comes packed with new age technology, software and Artificial Intelligence that work in the background to deliver wellness and tranquillity during transit. Providing an extremely premium yet simple and calming customer experience, this concept will be fairly accessible to a majority of customers of fast growing, high volume segments of today. With this, TPEM is all set to unleash a new breed of EVs that will redefine the automobile space. This path breaking EV will be introduced to the market by 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220429005300/en/

Speaking at this landmark occasion, Mr. N Chandrasekaran, Chairman, Tata Sons and Tata Motors said, “While making the AVINYA Concept a reality, the central idea was to offer a mobility solution like no other – a state of the art software on wheels that is well designed, sustainable and reduces the planet’s carbon footprint. Green Mobility is at the nucleus of TPEM, and the AVINYA Concept is the perfect reflection of what the company stands for – a creation that will not only accelerate the adoption of EVs but also lead this movement. Furthermore, at the Tata group, we are uniquely positioned to bring all the expertise that is necessary to build these mobility solutions and we are confident that in years to come we will make a larger and sustainable impact not only in India but globally as well.”

Adding to this, Mr. Shailesh Chandra, Managing Director, Tata Motors Passenger Vehicles Ltd., and Tata Passenger Electric Mobility Ltd. said, “It is indeed a matter of pride for us at TPEM to present the AVINYA Concept to the world, a vision pivotal in signalling a ‘New Paradigm’. Holding on to its values of Simplicity, Timelessness, Effortlessness and Grace, the AVINYA is not only a concept but is our new identity, an identity which is here to challenge the status quo. It gives me an intense sense of optimism to present a new typology of vehicles that will introduce the automobile industry to options beyond mobility – a tranquil space which will offer you a complete sensory experience while on the move. At its heart, the AVINYA Concept has ‘IN’, which demonstrates our Indian roots and highlights how we pride ourselves in discovering new ways to move and power vehicles. The AVINYA Concept is the fruition of our first idea built on our Pure EV GEN 3 architecture, enabling us to produce a range of globally competitive EVs. Our vision for pure EVs is focused on delivering wellness and rejuvenation while traveling, backed by cutting-edge technologies, aimed at improving the overall quality of life.”

A TIMELESS DESIGN:

Originally inspired by a catamaran, the AVINYA Concept is an uncompromising vision for electric mobility. With a new silhouette, this concept is a mixology of the best of the worlds – it a product which combines the essence of a premium hatch to the luxuries and versatility of an SUV and the roominess and functionality of an MPV – all put together to create something new and beautiful. A significant highlight on the front and the rear of the vehicle is the new identity. This new identity as a part of the DRL is a subtle nod to our commitment to enhance the quality of life and is a pivotal step in the evolution of EVs. It is also the manifesto and emphasises the Horizon and the Infinite possibilities that the Gen 3 electrification will offer. Gliding to the sides, one is met by the ‘Butterfly’ doors, which welcome you with open arms to a class leading spacious interior which is sure to make its inmates feel calm.

The AVINYA Concept focuses on a human centric design and promises a sensory journey of its own. From the skydome that enhances the overall sense of space and natural light to the functional console inspired steering wheel, to the voice activated systems for a deeper interface for all its passengers, to the sustainable materials being used, that communicate the ethos of the product and finally the finishing touch of the aroma diffuser – that envelopes you in an ambience that is serene and soothing.

Furthermore, envisaging a future trend, this concept is designed to believe that lesser screen time is the way to go. Taking this into consideration the AVINYA Concept has been made screen-less, to bar any distractions inside the car and create a stress free environment for the mind and soul.

A PURE EV AT ITS CORE:

The AVINYA Concept stands for empathetic mobility, a machine that is engineered to be smart, spacious, sustainable yet techy. The agile and robust Pure EV GEN 3 Architecture offers this concept with a flexible design while boasting of next generation connectivity, advanced driver assistance systems and enhanced performance and efficiency. Pioneered out of India for the world, this global platform offers high structural safety and has the next level of water proofing and dust protection, making it ready for all forms of terrains.

This architecture is built with the use of next-gen materials, efficient electronic componentry and proprietary energy management strategies & algorithms for efficiency management. Use of light-weight materials, and optimized structure for an EV only powertrain with enabled appropriate stiffness, helps minimize the overall mass, leading to good weight management. Furthermore, the battery used will support an ultra-fast charge capability, in line with the infrastructure evolution, pumping a minimum 500 kms range in under 30 minutes. The overall philosophy for enhanced range would be ‘Minimize- Maximize – Optimize’.

Drawing inspiration from human sensory cues whilst promising a stress-free experience with every drive, the AVINYA stands by the concept of minimalism and is a leap forward in the right direction, making it the absolute regiment of sustainable movement.

To know more about this impressive Concept, kindly refer to the detailed concept note.

Link:

ClickThru

Social Media:

https://www.facebook.com/TataMotorsGroup/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye